Bayesian meta‐analysis for evaluating treatment effectiveness in biomarker subgroups using trials...
During drug development, evidence can emerge to suggest a treatment is more effective in a specific patient subgroup. Whilst early trials may be conducted in biomarker-mixed populations, later...
onlinelibrary.wiley.com